| Income Statement |
| Operating Expenses | 1.96M |
|
| Research and Development Expense | 1.51M |
| Selling, General and Administrative Expense | 451.00K |
| Operating Income | -1.96M |
| Net Income | -1.83M |
| Net Income Common Stock | -1.83M |
| Net Income Common Stock (USD) | -1.83M |
| Consolidated Income | -1.83M |
| Earnings per Basic Share | -0.02 |
| Earnings per Basic Share (USD) | -0.02 |
| Earnings per Diluted Share | -0.02 |
| Earning Before Interest & Taxes (EBIT) | -1.83M |
| Earning Before Interest & Taxes (USD) | -1.83M |
| Weighted Average Shares | 93.68M |
| Weighted Average Shares Diluted | 93.68M |
| Balance Sheet |
| Cash and Equivalents | 509.00K |
| Cash and Equivalents (USD) | 509.00K |
| Investments | 8.58M |
| Investments Current | 8.58M |
| Current Assets | 9.23M |
| Property, Plant & Equipment Net | 16.73M |
| Total Assets | 26.24M |
| Current Liabilities | 650.00K |
| Total Liabilities | 795.00K |
| Accumulated Retained Earnings (Deficit) | -69.17M |
| Shareholders Equity | 25.45M |
| Shareholders Equity (USD) | 25.45M |
| Assets Non-Current | 17.01M |
| Liabilities Non-Current | 145.00K |
| Trade and Non-Trade Payables | 650.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 4.00K |
| Net Cash Flow from Financing | 1.74M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 346.00K |
| Issuance (Purchase) of Equity Shares | 1.74M |
| Net Cash Flow from Investing | -14.00K |
| Net Cash Flow - Investment Acquisitions and Disposals | -14.00K |
| Net Cash Flow from Operations | -1.37M |
| Share Based Compensation | 100.00K |